Methylation profiling

Dataset Information

0

Ataxia-telangiectasia mutated kinase disruption enhances the efficacy of radiation therapy in spatially-directed diffuse midline gliomas


ABSTRACT: Diffuse midline gliomas (DMGs) are lethal brain tumors characterized by p53-inactivating mutations and oncohistone H3.3K27M mutations that rewire the cellular response to genotoxic stress. Using RCAS/tv-a retroviruses and Cre recombinase to inactivate p53 and induce native H3.3K27M mutations in a lineage- and spatially-directed manner, we generated primary mouse tumors that recapitulate human DMG. Disrupting ataxia-telangiectasia mutated kinase (ATM) enhanced the efficacy of radiation therapy in murine and patient-derived DMG models, increasing survival. Microscopy-based in situ sequencing was used to spatially resolve transcriptional profiles in >750,000 single cells with or without ATM disruption and radiation therapy, revealing altered immune-neoplastic and endothelial cell interactions after treatment. An allelic series of primary murine DMG models with different p53 mutations confirmed that transactivation-independent p53 activity is a key mediator of radiosensitivity after ATM disruption. Our findings contribute primary DMG mouse models with deep profiling and reveal the mechanisms of treatment response to an actionable therapeutic strategy.

ORGANISM(S): Mus musculus

PROVIDER: GSE284759 | GEO | 2025/06/16

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2023-11-04 | GSE246584 | GEO
2024-07-30 | E-MTAB-13471 | biostudies-arrayexpress
2021-10-05 | GSE184934 | GEO
| PRJNA1033668 | ENA
2021-10-05 | GSE184936 | GEO
2021-10-05 | GSE184935 | GEO
2022-09-02 | GSE185280 | GEO
2020-05-13 | MODEL2005130001 | BioModels
2024-10-11 | GSE245716 | GEO
2022-12-25 | GSE190454 | GEO